Aspirin reduces the mortality rate of colorectal cancer

Patients with colorectal cancer who take one aspirin daily can reduce the risk of death (less than 29% of the risk of dying from this cancer and less than 21% for other causes).

This conclusion is drawn from the work carried out in early 1981 by Andrew Chan and colleagues at Massachusetts General Hospital, USA, based on 1,300 patients with colorectal cancer, half of whom the number of them added aspirin to their daily prescription.

The benefits of aspirin for this disease are thought to be due to its inhibitory effect on the COX-2 enzyme, responsible for the inflammatory response and proliferation of cells.

Although this effect has been confirmed, experts still do not recommend taking aspirin for the purpose of prevention because aspirin can cause many side effects, such as irritating the stomach, intestines and causing bleeding. Digest.

Furthermore, most patients do not produce enough COX-2 enzymes to be sensitive to the effects of aspirin./.